Robert bradway born march

  • Robert bradway born dead
  • Robert bradway born april
  • Robert bradway born march

    • Seeking efficiency in executive compensation benchmarking?

    Unlock Efficiency in Executive Compensation Benchmarking with CompAnalyst Executive

    CompAnalyst Executive

    As Chief Executive Officer and President at AMGEN INC, Robert A. Bradway made $22,, in total compensation. Of this total $1,, was received as a salary, $4,, was received as a bonus, $4,, was received in stock options, $11,, was awarded as stock and $, came from other types of compensation.

    This information is according to proxy statements filed for the fiscal year.

    Chief Executive Officer and President

    The chart on this page features a breakdown of the total annual pay for Robert A. Bradway, Chief Executive Officer and President at AMGEN INC as reported in their proxy statements.

    Robert bradway born After Kevin W. Sharer left, Robert A. Bob Bradway became the representative of California-based biopharmaceutical company, Amgen Inc. Prior to that, he worked at Morgan Stanley for nearly two decades. Scroll down to view details such as age, career, net worth, and email address on this wiki.

    Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. AMGEN INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. AMGEN INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

    Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

    Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories.

    Robert bradway born date

    Robert A. Bradway born or [ 1 ] is an American businessman. He is the chairman and chief executive officer of Amgen. Bradway holds a B. Bradway joined Morgan Stanley in New York in as a health care industry investment banker.

    Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

    Other Executives at this Company

    Robert A. Bradway

    BONUS + INCENTIVE COMP

    $4,,

    TOTAL CASH COMPENSATION

    $6,,

    STOCK AWARD VALUE

    $11,,

    OPTION AWARD VALUE

    $4,,

    For its fiscal year, AMGEN INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.

    CEO NameCEO PayMedian Employee PayCEO Pay Ratio
    Robert A. BradwayCEO Pay$22,,Median Employee Pay$,CEO Pay Ratio

    Browse Executives by First Name

    Browse Companies by Company Name

    This report is not for commercial use.

    Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

    Robert bradway born today Home About History. Why Gold? Newsletters Press Releases Annual Reports. Our Mission The mission of the CEO Roundtable on Cancer is to make continual progress toward the elimination of cancer as a personal disease and public health problem through initiatives that reduce the risk of cancer, enable early diagnosis, facilitate access to treatment, and hasten the discovery of effective therapies. The CEO Roundtable on Cancer brings together leaders from industry, academia, and government to accelerate progress in cancer prevention, diagnosis, and treatment.

    Use of Data / Disclaimer

    The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information.

    For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code).

    Robert bradway amgen Robert A. Bradway is Amgen's chairman and chief executive officer. Bradway became chairman in January and chief executive officer in May Bradway served as the company's president and chief operating officer from May to May , and was appointed to the Amgen Board of Directors in October He joined the company in as vice president, Operations Strategy, and served as executive vice president and chief financial officer from April to May

    You may also find the annual proxy statement by going directly to the company's website.

    What is a proxy statement?

    A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within days after the end of its fiscal year.

    The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC. The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives.

    Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.